323 related articles for article (PubMed ID: 15452072)
21. Topical and systemic absorption in delivery of dexamethasone to the anterior and posterior segments of the eye.
Sigurdsson HH; Konráethsdóttir F; Loftsson T; Stefánsson E
Acta Ophthalmol Scand; 2007 Sep; 85(6):598-602. PubMed ID: 17645424
[TBL] [Abstract][Full Text] [Related]
22. Intraocular carboplatin concentrations following intravenous administration for human intraocular retinoblastoma.
Abramson DH; Frank CM; Chantada GL; de Totah AB; de Pifano IT; Ramírez GT; Gomez RT; Fandino AT; Tran HT; Madden TJ; Dunkel IJ
Ophthalmic Genet; 1999 Mar; 20(1):31-6. PubMed ID: 10415463
[TBL] [Abstract][Full Text] [Related]
23. Episcleral implants for topotecan delivery to the posterior segment of the eye.
Carcaboso AM; Chiappetta DA; Opezzo JA; Höcht C; Fandiño AC; Croxatto JO; Rubio MC; Sosnik A; Abramson DH; Bramuglia GF; Chantada GL
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2126-34. PubMed ID: 19834044
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of intraocular drug delivery of Oregon green 488-labeled triamcinolone by subtenon injection using ocular fluorophotometry in rabbit eyes.
Lee SJ; Kim ES; Geroski DH; McCarey BE; Edelhauser HF
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4506-14. PubMed ID: 18503001
[TBL] [Abstract][Full Text] [Related]
25. Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma.
Tsui JY; Dalgard C; Van Quill KR; Lee L; Grossniklaus HE; Edelhauser HF; O'Brien JM
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):490-6. PubMed ID: 18234990
[TBL] [Abstract][Full Text] [Related]
26. Delivery of gentamicin to the rabbit eye by drug-loaded hydrogel iontophoresis.
Eljarrat-Binstock E; Raiskup F; Stepensky D; Domb AJ; Frucht-Pery J
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2543-8. PubMed ID: 15277475
[TBL] [Abstract][Full Text] [Related]
27. Anecortave acetate as single and adjuvant therapy in the treatment of retinal tumors of LH(BETA)T(AG) mice.
Jockovich ME; Murray TG; Escalona-Benz E; Hernandez E; Feuer W
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1264-8. PubMed ID: 16565356
[TBL] [Abstract][Full Text] [Related]
28. Ocular tissue distribution of betamethasone after anterior-episcleral, posterior-episcleral, and anterior-intrascleral placement of nonbiodegradable implants.
Okabe K; Kimura H; Okabe J; Ogura Y
Retina; 2007; 27(6):770-7. PubMed ID: 17621189
[TBL] [Abstract][Full Text] [Related]
29. Ischemic necrosis and atrophy of the optic nerve after periocular carboplatin injection for intraocular retinoblastoma.
Schmack I; Hubbard GB; Kang SJ; Aaberg TM; Grossniklaus HE
Am J Ophthalmol; 2006 Aug; 142(2):310-5. PubMed ID: 16876514
[TBL] [Abstract][Full Text] [Related]
30. Does a nanomolecule of Carboplatin injected periocularly help in attaining higher intravitreal concentrations?
Shome D; Poddar N; Sharma V; Sheorey U; Maru GB; Ingle A; Sarin R; Banavali S; Dikshit R; Jain V; Honavar S; Bellare J
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5896-900. PubMed ID: 19628744
[TBL] [Abstract][Full Text] [Related]
31. Intraocular concentrations of chemotherapeutic agents after systemic or local administration.
Mendelsohn ME; Abramson DH; Madden T; Tong W; Tran HT; Dunkel IJ
Arch Ophthalmol; 1998 Sep; 116(9):1209-12. PubMed ID: 9747681
[TBL] [Abstract][Full Text] [Related]
32. Topotecan combination chemotherapy in two new rodent models of retinoblastoma.
Laurie NA; Gray JK; Zhang J; Leggas M; Relling M; Egorin M; Stewart C; Dyer MA
Clin Cancer Res; 2005 Oct; 11(20):7569-78. PubMed ID: 16243833
[TBL] [Abstract][Full Text] [Related]
33. Delivery from episcleral exoplants.
Pontes de Carvalho RA; Krausse ML; Murphree AL; Schmitt EE; Campochiaro PA; Maumenee IH
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4532-9. PubMed ID: 17003449
[TBL] [Abstract][Full Text] [Related]
34. Ocular motility changes after subtenon carboplatin chemotherapy for retinoblastoma.
Mulvihill A; Budning A; Jay V; Vandenhoven C; Heon E; Gallie BL; Chan HS
Arch Ophthalmol; 2003 Aug; 121(8):1120-4. PubMed ID: 12912689
[TBL] [Abstract][Full Text] [Related]
35. A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide.
Robinson MR; Lee SS; Kim H; Kim S; Lutz RJ; Galban C; Bungay PM; Yuan P; Wang NS; Kim J; Csaky KG
Exp Eye Res; 2006 Mar; 82(3):479-87. PubMed ID: 16168412
[TBL] [Abstract][Full Text] [Related]
36. Transscleral diffusion of carboplatin: an in vitro and in vivo study.
Simpson AE; Gilbert JA; Rudnick DE; Geroski DH; Aaberg TM; Edelhauser HF
Arch Ophthalmol; 2002 Aug; 120(8):1069-74. PubMed ID: 12149061
[TBL] [Abstract][Full Text] [Related]
37. Local carboplatin therapy in transgenic murine retinoblastoma.
Harbour JW; Murray TG; Hamasaki D; Cicciarelli N; Hernández E; Smith B; Windle J; O'Brien JM
Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1892-8. PubMed ID: 8759359
[TBL] [Abstract][Full Text] [Related]
38. Carboplatin loaded polymethylmethacrylate nano-particles in an adjunctive role in retinoblastoma: an animal trial.
Shome D; Kalita D; Jain V; Sarin R; Maru GB; Bellare JR
Indian J Ophthalmol; 2014 May; 62(5):585-9. PubMed ID: 24881606
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic monitoring of carboplatin dosing in a premature infant with retinoblastoma.
Picton SV; Keeble J; Holden V; Errington J; Boddy AV; Veal GJ
Cancer Chemother Pharmacol; 2009 Mar; 63(4):749-52. PubMed ID: 18607591
[TBL] [Abstract][Full Text] [Related]
40. [Preoperative intraperitoneal versus intravenous carboplatin chemotherapy for advanced gastric cancer, pharmacokinetics and drug accumulation study].
Wang J; Chen J; Ma S
Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):300-2. PubMed ID: 11038765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
